Axoltis ALS drug misses Phase 2 endpoint
Why it matters: ALS remains notoriously difficult to treat, and the SEALS study did not establish an effect…
UiPath Launches Agentic AI Solutions to Break Administrative & Financial Bottlenecks for Clinicians and Healthcare Admins
Offerings for medical records summarization, claim denial prevention and resolution, and prior authorization streamline payer/provider collaboration and dramatically…
Leyden Labs reports first human data for intranasal flu prevention antibody
The update covers two phase 1 trials in which a total of 143 healthy volunteers received intranasal doses…